🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

José Madrazo

Johns Hopkins University

ORCID: 0000-0002-9966-2703

Also affiliated with Johns Hopkins Medicine

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Unsupervised machine learning demonstrates the prognostic value of TAPSE/PASP ratio among hospitalized patients with COVID‐19”.

Unsupervised machine learning demonstrates the prognostic value of TAPSE/PASP ratio among hospitalized patients with COVID‐19

Echocardiography(2022)10.1111/echo.15432
N/A
0DataRank · unranked
12 citations

Karan Kapoor, Joseph Meyer, Jim Lu, Erin Goerlich, Thomas S. Metkus +8 more

Insulin resistance is associated with subclinical myocardial dysfunction and reduced functional capacity in heart failure with preserved ejection fraction

Journal of Cardiology(2023)10.1016/j.jjcc.2023.06.008
N/A
0DataRank · unranked
23 citations

Gabriel E. Shaya, Monica Mukherjee, Erin D. Michos, José Madrazo, Lena Mathews +4 more

Eighteen‐Month Real‐World Experience Using Mavacamten for Treatment of Obstructive Hypertrophic Cardiomyopathy in a Racially Diverse Population

Journal of the American Heart Association(2024)10.1161/jaha.123.034069
N/A
0DataRank · unranked
27 citations

Alessio Gasperetti, Victoria Blake, Bryana Rivers, Ali A. Kassamali, Edward K. Kasper +5 more

Mavacamten in Right Ventricular Outflow Tract Obstruction

JACC Case Reports(2024)10.1016/j.jaccas.2024.102397
N/A
0DataRank · unranked
4 citations

Richard T. Carrick, Chloe Duvall, Faisal Rahman, Matthew W. Martinez, José Madrazo +2 more

External validation of atrial fibrillation risk prediction tools in a racially diverse cohort of patients with hypertrophic cardiomyopathy

Heart Rhythm(2025)10.1016/j.hrthm.2025.05.046
N/A
0DataRank · unranked
6 citations

Ali Asghar Kassamali, Jeff Ehmsen, Bryana Rivers, Alessio Gasperetti, Kathérine C. Wu +4 more

Concurrent Use of Tafamidis and Mavacamten for Transthyretin Cardiac Amyloidosis With Severe Outflow Tract Obstruction

JACC Case Reports(2025)10.1016/j.jaccas.2025.104495
N/A
0DataRank · unranked
0 citations

Joban Vaishnav, Matthew J. Czarny, Victoria Blake, Vrinda Gupta, Jeremy Johnson +4 more

Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study

medRxiv(2025)10.1101/2025.09.15.25335783
N/A
0DataRank · unranked
0 citations

Jack Wiedrick, Daniele Massera, Elizabeth Adlestein, Sumar Frejat, Matteo Castrichini +47 more